Categories: News

Information about the end of mandatory offer of share repurchase

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Joint Stock Company “Olainfarm” hereby informs that today, 7th December 2021 at 16:00 JSC AB CITY will end the mandatory share repurchase offer process.

Repurchase price is EUR 9.26 (nine euros and 26 cents) for one share.

Additional information:

Jānis Leimanis

JSC Olainfarm Management board member

Phone: +371 29269424

Email: janis.leimanis@olainfarm.com

Staff

Recent Posts

Fangzhou Launches Otsuka’s Third-Generation Leukemia Drug Ponatinib on its Platform

GUANGZHOU, China, May 5, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in…

3 hours ago

SprintRay Appoints Dr. Meena Barsoum as Global Head of Clinical Strategy

LOS ANGELES, May 5, 2025 /PRNewswire/ -- SprintRay, the global leader in dental 3D printing,…

3 hours ago

FendX Announces Share Issuance Pursuant to IP License Agreement

Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

7 hours ago

The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote

DANA POINT, Calif.--(BUSINESS WIRE)--The Lens, LSI’s executive-focused medtech magazine, proudly unveils Volume 2, Edition 3,…

9 hours ago

eMed Announces Collaboration with Aon to Provide a Digital GLP-1 Benefit Program for Aon colleagues

Partnership provides virtual clinical support with data driven measurement to improve adherence for obesity management MIAMI, May 5, 2025 /PRNewswire/ -- eMed®,…

9 hours ago